ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Olmesartan-Amlodipin-HCT-Mepha 20 mg/5 mg/12,5 mg, Lactab - 28
67602001 Mepha Pharma AG
Olmesartan-Amlodipin-HCT-Mepha 20 mg/5 mg/12,5 mg, Lactab11.08.2020
Generic11.08.2020
Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide (C09DX03) 
WHO-DDD 
02.07.20.28
02.07.20. 
B  
Yes 
IPCI
15.93Yes
    
10 %33.75
  
7680676020019Synthetika
  
Composition
Filmtablette: olmesartanum medoxomilum 20 mg, amlodipinum 5 mg ut amlodipini besilas 6.93 mg, hydrochlorothiazidum 12.5 mg, cellulosum microcristallinum, lactosum monohydricum 19 mg, crospovidonum povidonum K 30, carboxymethylamylum natricum A corresp. natrium 0.21 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 4000, talcum, pro compresso obducto.
Packungsbestandteile
Coated tablets 
 
Active AgentDoseadditional_information
Amlodipine5 mg 
Hydrochlorothiazide12.5 mg 
Olmesartanum Medoxomilum20 mgFilmtablette
BAG: Active AgentDose
Amlodipine5 mg
Hydrochlorothiazide12.5 mg
Olmesartan Medoxomil20 mg
 
Inactive agentsDoseadditional_information
Carboxymethylamylum Natricum A  
Cellulosum Microcristallinum  
Crospovidonum Povidonum K30  
E 171 color.
Lactose Monohydrate19 mg 
Macrogol4000  
Magnesii Stearas  
Poly(Alcohol Vinylicus) Überzug
Pro Compresso Obducto  
Silica Colloidalis Anhydrica  
Talcum  
 
Source
Data was imported : 07.01.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home